These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 24857081)

  • 1. Integrative oncology: an overview.
    Deng G; Cassileth B
    Am Soc Clin Oncol Educ Book; 2014; ():233-42. PubMed ID: 24857081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complementary or alternative medicine in cancer care-myths and realities.
    Deng G; Cassileth B
    Nat Rev Clin Oncol; 2013 Nov; 10(11):656-64. PubMed ID: 23897081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative medicine in hematology/oncology: benefits, ethical considerations, and controversies.
    Rosenthal DS; Dean-Clower E
    Hematology Am Soc Hematol Educ Program; 2005; ():491-7. PubMed ID: 16304425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating complementary therapies into mainstream cancer care: which way forward?
    Robotin MC; Penman AG
    Med J Aust; 2006 Oct; 185(7):377-9. PubMed ID: 17014406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An approach for integrating complementary-alternative medicine into primary care.
    Frenkel MA; Borkan JM
    Fam Pract; 2003 Jun; 20(3):324-32. PubMed ID: 12738703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why integrative oncology? Complementary therapies are increasingly becoming part of mainstream care.
    Cassileth B
    Oncology (Williston Park); 2006 Sep; 20(10):1302. PubMed ID: 17024875
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of a blended-learning training concept to train oncology physicians to advise their patients about complementary and integrative medicine (KOKON-KTO): study protocol for a prospective, multi-center, cluster-randomized trial.
    Helmer SM; Rogge AA; Fischer F; Pach D; Horneber M; Roll S; Witt CM
    Trials; 2019 Jan; 20(1):90. PubMed ID: 30696465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling an integrative oncology program within a community-centered oncology service in Israel.
    Ben-Arye E; Schiff E; Shapira C; Frenkel M; Shalom T; Steiner M
    Patient Educ Couns; 2012 Dec; 89(3):423-9. PubMed ID: 22401792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future directions of CAM research in pediatric oncology.
    Post-White J; Hawks R; O'Mara A; Ott MJ
    J Pediatr Oncol Nurs; 2006; 23(5):265-8. PubMed ID: 16902081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatric benefits of integrative therapies in patients with cancer.
    Cassileth BR
    Int Rev Psychiatry; 2014 Feb; 26(1):114-27. PubMed ID: 24716505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrative approach to addressing clinical issues in complementary and alternative medicine in an outpatient oncology center.
    Chong OT
    Clin J Oncol Nurs; 2006 Feb; 10(1):83-8. PubMed ID: 16482732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative oncology in North America.
    Sagar SM
    J Soc Integr Oncol; 2006; 4(1):27-39. PubMed ID: 16737670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Oncology Society of Australia position statement on the use of complementary and alternative medicine by cancer patients.
    Braun L; Harris J; Katris P; Cain M; Dhillon H; Koczwara B; Olver I; Robotin M
    Asia Pac J Clin Oncol; 2014 Dec; 10(4):289-96. PubMed ID: 25244342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complementary therapies and integrative oncology in lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition).
    Cassileth BR; Deng GE; Gomez JE; Johnstone PA; Kumar N; Vickers AJ;
    Chest; 2007 Sep; 132(3 Suppl):340S-354S. PubMed ID: 17873179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modeling integrative oncology care program for Arab patients in north Israel: towards quality of life improvement during chemotherapy].
    Ben-Arye E; Dagash J; Silbermann M; Saad B; Steiner M; Popper-Giveon A; Lev E; Agbarya A; Sela GB; Karkabi K; Schiff E
    Harefuah; 2015 Jan; 154(1):26-30, 69, 68. PubMed ID: 25796671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Training oncology physicians to advise their patients on complementary and integrative medicine: An implementation study for a manual-guided consultation.
    Witt CM; Helmer SM; Schofield P; Wastell M; Canella C; Thomae AV; Rogge AA
    Cancer; 2020 Jul; 126(13):3031-3041. PubMed ID: 32286693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open dialogue about complementary and alternative medicine (CAM) integrated in conventional oncology care, characteristics and impact. A systematic review.
    Stie M; Jensen LH; Delmar C; Nørgaard B
    Patient Educ Couns; 2020 Nov; 103(11):2224-2234. PubMed ID: 32563705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Integrating complementary medicine in oncology supportive care: assessment of patients' needs and expectations during chemotherapy].
    Shalom T; Schiff E; Steiner M; Katz M; Ben-Arye E
    Harefuah; 2011 Aug; 150(8):642-5, 689. PubMed ID: 21939114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the definition of complementary, alternative, and integrative medicine: societal mega-stereotypes vs. the patients' perspectives.
    Caspi O; Sechrest L; Pitluk HC; Marshall CL; Bell IR; Nichter M
    Altern Ther Health Med; 2003; 9(6):58-62. PubMed ID: 14618859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing holistic healthcare needs of oncology patients: Implementation and evaluation of a complementary and alternative medicine (CAM) course within an elective module designed for healthcare professionals.
    Klafke N; Homberg A; Glassen K; Mahler C
    Complement Ther Med; 2016 Dec; 29():190-195. PubMed ID: 27912946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.